Keywords: sanofi-aventis, menactra, linked, cases, gb, syndrome, centers

Sanofi-Aventis's Menactra linked to three cases of GB syndrome

Article | 17 April 2006

Print This

The US Centers for Disease Control and Prevention says it is concerned that three cases of Guillain-Barre syndrome, an inflammatory ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in